Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Bike lane advocates to challenge Ford government’s removal plans at Supreme Court

October 13, 2026

Selma Blair charged with assault after allegedly attacking flight attendants

October 13, 2026

Google finally releases Gemini 4 Argon

October 13, 2026

Online predators coercing children to commit violence, Durham police warn

October 13, 2026

‘Breaking Bad’ actor RJ Mitte dead at 34

October 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Formulation Development Outsourcing Market Report 2026
Press Release

Formulation Development Outsourcing Market Report 2026

By News RoomMay 11, 20263 Mins Read
Formulation Development Outsourcing Market Report 2026
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, May 11, 2026 (GLOBE NEWSWIRE) — The “Formulation Development Outsourcing Market Report 2026” has been added to ResearchAndMarkets.com’s offering.

The formulation development outsourcing market is poised for dynamic growth, forecasted to expand from $32.32 billion in 2025 to $35.45 billion in 2026 at a 9.7% CAGR. This surge is driven by complex pharmaceutical R&D, more drug candidates, specialized expertise demands, and heightened regulatory scrutiny. By 2030, the market is expected to reach $53.3 billion, driven by the rising demand for biologics, personalized medicine, and advanced formulation technologies, maintaining a CAGR of 10.7%.

The industry is witnessing a shift towards the outsourcing of complex drug formulations, adopting quality by design (QbD) approaches, and a growing need for injectable and specialized dosage forms. Companies are expanding scale-up and technology transfer services to maintain regulatory compliance and meet accelerated time-to-market demands.

The upward trend in drug demand, underscored by a 13.5% increase in EU exports of medicinal products in 2024, is fueling market growth. Formulation development outsourcing is essential in biopharmaceutical development, enhancing drug delivery systems and offering cost-effective solutions for pharmaceutical firms.

Innovative solutions, like AI-powered generative cloud platforms, are transformative for the industry. Such platforms expedite molecular design, drug discovery, and other R&D functions. NVIDIA’s BioNeMo Cloud, launched in 2023, exemplifies this innovation, offering pre-trained AI models for research acceleration. This service is already adopted by leaders like Amgen to drive efficient, data-driven innovation.

In April 2024, CoreRx, Inc. acquired Societal CDMO Inc., enhancing its capabilities in formulation development and scale-up manufacturing to better serve pharmaceutical clients. This acquisition supports CoreRx’s strategy to offer integrated development-to-commercial manufacturing services.

Key players in this thriving market include Syngene International Ltd., Aizant Drug Research Solutions, Catalent Inc., Intertek Group plc, Recipharm AB, and many others. These companies are central to the market’s expansion, offering critical services like ingredient sourcing, stability studies, and regulatory support.

North America led the global market in 2025, with major regions such as Asia-Pacific, Europe, and Africa also seeing significant activity. The market’s revenues are generated from direct sales, grants, and more, focused on service provision instead of resales. With a continual push towards innovation and efficiency in drug development processes, the formulation development outsourcing market stands as a cornerstone of the global pharmaceutical landscape.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2026 – 2030
Estimated Market Value (USD) in 2026 $35.45 Billion
Forecasted Market Value (USD) by 2030 $53.3 Billion
Compound Annual Growth Rate 10.7%
Regions Covered Global


Major Trends

  • Increasing Outsourcing of Complex Drug Formulations
  • Rising Adoption of Quality by Design Approaches
  • Growing Demand for Injectable and Specialized Dosage Forms
  • Expansion of Scale-Up and Technology Transfer Services
  • Enhanced Focus on Regulatory-Compliant Formulation Development

Companies Featured

  • Syngene International Ltd.
  • Aizant Drug Research Solutions Private Limited.
  • Catalent Inc.
  • Intertek Group PLC
  • Recipharm AB
  • SGS S.A.
  • Lonza Group AG
  • Eurofins Scientific SE
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International Inc.
  • Piramal Pharma Limited.
  • Quotient Sciences Ltd.
  • Almac Group
  • Patheon
  • Evonik Industries AG
  • Metrics Contract Services
  • Aenova Group
  • Fareva Group
  • Vetter Pharma International GmbH
  • Aesica Pharmaceuticals
  • WuXi AppTec
  • Formosa Laboratories Inc.
  • Aptuit LLC
  • ProPharma Group
  • Laurus Labs Limited

For more information about this report visit https://www.researchandmarkets.com/r/jfpte6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Formulation Development Outsourcing Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Selma Blair charged with assault after allegedly attacking flight attendants

October 13, 2026

Google finally releases Gemini 4 Argon

October 13, 2026

Online predators coercing children to commit violence, Durham police warn

October 13, 2026

‘Breaking Bad’ actor RJ Mitte dead at 34

October 13, 2026

Latest News

DLSS 5 gets toned down for its Hogwarts Legacy debut next month

October 13, 2026

Canada joins other nations denouncing Iran’s air base attack plot in the UK

October 13, 2026

Apple’s HomePod Mini 2 is available to preorder

October 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version